Literature DB >> 365740

Inhibition of the secretory activity of Escherichia coli heat-stable enterotoxin by indomethacin.

G L Madsen, F C Knoop.   

Abstract

The effect of indomethacin on the net intestinal accumulation of fluid induced by Escherichia coli heat-stable (ST) enterotoxin in the infant mouse model was examined. Indomethacin, when administered with ST enterotoxin, caused a striking decrease in net intestinal fluid accumulation. This inhibition of ST activity was dose dependent with various concentrations of indomethacin (P less than 0.01). A significant inhibition of toxicity was also observed when indomethacin was given before (P less than 0.01) or after (P less than 0.02) ST enterotoxin challenge. No significant differences in fluid accumulation were observed between control mice treated with buffer alone and those challenged with only indomethacin. These data indicate that indomethacin markedly decreases the net intestinal fluid accumulation induced by E. coli ST enterotoxin. Further studies on the potential use of indomethacin in both the prophylaxis and the therapy of diarrheal diseases appear warranted.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 365740      PMCID: PMC422128          DOI: 10.1128/iai.22.1.143-147.1978

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  Indomethacin-responsive pancreatic cholera.

Authors:  B M Jaffe; D F Kopen; K DeSchryver-Kecskemeti; R L Gingerich; M Greider
Journal:  N Engl J Med       Date:  1977-10-13       Impact factor: 91.245

2.  Role of cyclic GMP in the action of heat-stable enterotoxin of Escherichia coli.

Authors:  J M Hughes; F Murad; B Chang; R L Guerrant
Journal:  Nature       Date:  1978-02-23       Impact factor: 49.962

3.  Cholera enterotoxin: failure of anti-inflammatory agents to prevent cyclic AMP accumulation.

Authors:  H R Bourne
Journal:  Nature       Date:  1973-02-09       Impact factor: 49.962

4.  Patterns of loss of enterotoxigenicity by Escherichia coli isolated from adults with diarrhea: suggestive evidence for an interrelationship with serotype.

Authors:  D J Evans; D G Evans; H L DuPont; F Orskov; I Orskov
Journal:  Infect Immun       Date:  1977-07       Impact factor: 3.441

5.  Effects of prostaglandins and cholera enterotoxin on intestinal mucosal cyclic AMP accumulation. Evidence against an essential role for prostaglandins in the action of toxin.

Authors:  D V Kimberg; M Field; E Gershon; A Henderson
Journal:  J Clin Invest       Date:  1974-03       Impact factor: 14.808

6.  Effect of indomethacin on intestinal water transport in salmonella-infected rhesus monkeys.

Authors:  R A Giannella; W R Rout; S B Formal
Journal:  Infect Immun       Date:  1977-07       Impact factor: 3.441

7.  Stimulation of intestinal mucosal adenyl cyclase by cholera enterotoxin and prostaglandins.

Authors:  D V Kimberg; M Field; J Johnson; A Henderson; E Gershon
Journal:  J Clin Invest       Date:  1971-06       Impact factor: 14.808

8.  [Heat-stable Escherichia coli-enterotoxin: reduced action after administration of phenylbutazone in infant mice (author's transl)].

Authors:  H Ohgke; D Wagner
Journal:  Zentralbl Bakteriol Orig A       Date:  1977-07

9.  Bismuth subsalicylate inhibits activity of crude toxins of Escherichia coli and Vibrio cholerae.

Authors:  C D Ericsson; D G Evans; H L DuPont; D J Evans; L K Pickering
Journal:  J Infect Dis       Date:  1977-11       Impact factor: 5.226

10.  Action of Escherichia coli enterotoxin: adenylate cyclase behavior of intestinal epithelial cells in culture.

Authors:  H S Kantor; P Tao; C Wisdom
Journal:  Infect Immun       Date:  1974-06       Impact factor: 3.441

View more
  10 in total

1.  Effect of lodoxamide on the secretory response induced by Escherichia coli and Vibrio cholerae enterotoxins in infant mice.

Authors:  F C Knoop; D D Thomas
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

2.  Reversal of the biological activity of Escherichia coli heat-stable enterotoxin by disulfide-reducing agents.

Authors:  M M ElDeib; C R Dove; C D Parker; T L Veum; G M Zinn; A A White
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

3.  Characterization of the mechanism of action of Escherichia coli heat-stable enterotoxin.

Authors:  L A Dreyfus; L Jaso-Friedmann; D C Robertson
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

4.  Segmental differences in the effects of guanylin and Escherichia coli heat-stable enterotoxin on Cl- secretion in human gut.

Authors:  M Kuhn; K Adermann; J Jähne; W G Forssmann; G Rechkemmer
Journal:  J Physiol       Date:  1994-09-15       Impact factor: 5.182

5.  Effects of salicylate on intestinal absorption: in vitro and in vivo studies with enterotoxigenic micro-organisms.

Authors:  V Burke; M Gracey
Journal:  Gut       Date:  1980-08       Impact factor: 23.059

6.  Effect of chlorpromazine on the secretory activity of Escherichia coli heat-stable enterotoxin.

Authors:  D M Abbey; F C Knoop
Journal:  Infect Immun       Date:  1979-12       Impact factor: 3.441

7.  Studies on the mechanism of action of dioctyl sodium sulphosuccinate in the human jejunum.

Authors:  K J Moriarty; M J Kelly; R Beetham; M L Clark
Journal:  Gut       Date:  1985-10       Impact factor: 23.059

8.  Purification and characterization of Clostridium difficile toxin.

Authors:  R D Rolfe; S M Finegold
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

9.  Stimulation of calcium uptake and cyclic GMP synthesis in rat basophilic leukemia cells by Escherichia coli heat-stable enterotoxin.

Authors:  F C Knoop; D D Thomas
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

10.  Evaluation of BW942C, a novel antidiarrheal agent, against enterotoxins of Escherichia coli and Vibrio cholerae.

Authors:  D R Morgan; J Sellin; L Gutierrez; H L DuPont; L V Wood
Journal:  Infect Immun       Date:  1985-06       Impact factor: 3.441

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.